0001415889-24-002938.txt : 20240207 0001415889-24-002938.hdr.sgml : 20240207 20240207163918 ACCESSION NUMBER: 0001415889-24-002938 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240206 FILED AS OF DATE: 20240207 DATE AS OF CHANGE: 20240207 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cox Christopher Nixon CENTRAL INDEX KEY: 0002008212 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41944 FILM NUMBER: 24604873 MAIL ADDRESS: STREET 1: C/O ALTO NEUROSCIENCE, INC. STREET 2: 369 SOUTH SAN ANTONIO ROAD CITY: LOS ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Alto Neuroscience, Inc. CENTRAL INDEX KEY: 0001999480 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 834210124 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 BUSINESS PHONE: 773-255-5012 MAIL ADDRESS: STREET 1: 369 SOUTH SAN ANTONIO RD. CITY: LOS ALTOS STATE: CA ZIP: 94022 4 1 form4-02072024_090202.xml X0508 4 2024-02-06 0001999480 Alto Neuroscience, Inc. ANRO 0002008212 Cox Christopher Nixon C/O ALTO NEUROSCIENCE, INC. 369 SOUTH SAN ANTONIO ROAD LOS ALTOS CA 94022 true false false false 0 Common Stock 2024-02-06 4 C 0 588898 A 588898 I By Lightswitch Capital Fund I, L.P. Common Stock 2024-02-06 4 C 0 126755 A 715653 I By Lightswitch Capital Fund I, L.P. Series B Preferred Stock 2024-02-06 4 C 0 1250000 0 D Common Stock 588898 0 I By Lightswitch Capital Fund I, L.P. Series C Preferred Stock 2024-02-06 4 C 0 281917 0 D Common Stock 126755 0 I By Lightswitch Capital Fund I, L.P. Each share of Series B Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.1226069 for 1 basis and had no expiration date. The shares are directly held by Lightswitch Capital Fund I, L.P. ("Lightswitch Capital"), of which Lightswitch Capital GP, LLC ("Lightswitch GP") is the sole general partner and exercises voting and investment power over these shares. The Reporting Person is the Chief Executive Officer of Lightswitch GP and disclaims beneficial ownership of these securities, except to the extent of his proportionate pecuniary interest therein. Each share of Series C Preferred Stock was convertible at any time, at the holder's election, and automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering on a 2.2241 for 1 basis and has no expiration date. /s/ Erin R. McQuade, Attorney-in-Fact 2024-02-07